News
Sale of Spanish life insurance company Sa Nostra Vida completed
Sale of Spanish life insurance company Sa Nostra Vida completed
Orell Füssli AG: Orell Füssli presents growth strategy until 2028 at Capital Markets Day
Orell Füssli AG: Orell Füssli presents growth strategy until 2028 at Capital Markets Day
Edisun Power Europe AG: Edisun Power bond issue attracts strong interest at almost CHF 35 million
Edisun Power Europe AG: Edisun Power bond issue attracts strong interest at almost CHF 35 million
Kuros Biosciences Completes Enrollment of Randomized Stage of Phase 2 Trial for Fibrin-PTH
Kuros Biosciences Completes Enrollment of Randomized Stage of Phase 2 Trial for Fibrin-PTH
Implenia signs cooperation agreement with Deutsche Asset One and Union Investment for project developments in German residential real estate market
Implenia signs cooperation agreement with Deutsche Asset One and Union Investment for project developments in German residential real estate market
Helvetia Venture Fund invests in Urban Connect, a Swiss start-up for business mobility
Helvetia Venture Fund invests in Urban Connect, a Swiss start-up for business mobility
Kinarus Receives USPTO Notice of Allowance for Lead Therapeutic Candidate KIN001
Kinarus Receives USPTO Notice of Allowance for Lead Therapeutic Candidate KIN001
u-blox AG: u-blox announces results of Extraordinary Shareholder’s Meeting
u-blox AG: u-blox announces results of Extraordinary Shareholder’s Meeting
ABB E-mobility Raises Approx. CHF200 Million in a Pre-IPO Private Placement to Support Its Growth Journey
ABB E-mobility, a global leader in electric vehicle (EV) charging solutions, today announced that it has signed a pre-IPO private placement of approximately CHF200 million for newly issued shares
APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival
APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival
Leclanché confirms that the capital increase of CHF 41.3 million approved at its last AGM has been completed
Leclanché confirms that the capital increase of CHF 41.3 million approved at its last AGM has been completed
Energy transition and sustainability at the forefront of our thinking
Energy transition and sustainability at the forefront of our thinking
Leclanché announces 2022 semi-annual results and other important updates
Leclanché announces 2022 semi-annual results and other important updates
EQS-News: Significantly positive sales development at the Highlight Group
EQS-News: Significantly positive sales development at the Highlight Group
Baloise anticipates solid full-year results with reliable generation of cash
Baloise anticipates solid full-year results with reliable generation of cash